Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Babies were mostly born healthy from fathers who took finasteride, but some pregnancies ended early; more research is needed.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

Long-term finasteride treatment reduces depression and brain issues in obese male rats.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Finasteride improves urinary function in men for 2 years.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

Some drugs used to treat immune conditions may cause different types of hair loss.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Finasteride effectively treats male hair loss, increasing length and thickness.

5α-reductase inhibitors may increase the risk of depression and suicidal thoughts.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

5-ARI therapy may help prevent prostate cancer progression.

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.

The scalp microbiome is more diverse and may be more important in hair loss than the gut microbiome.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Finasteride may help reduce male hair loss and excessive hair growth by lowering DHT levels.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Testosterone in human pancreas cells boosts insulin production.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.